Glenmede Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.3M | Sell |
|
|||||
|
2024
Q4 | $1.94M | Buy |
|
|||||
|
2024
Q3 | $1.9M | Sell |
|
|||||
|
2024
Q2 | $62.3M | Sell |
|
|||||
|
2024
Q1 | $56.5M | Sell |
|
|||||
|
2023
Q4 | $70.8M | Sell |
|
|||||
|
2023
Q3 | $67.6M | Sell |
|
|||||
|
2023
Q2 | $62.6M | Sell |
|
|||||
|
2023
Q1 | $62.7M | Buy |
|
|||||
|
2022
Q4 | $55.1M | Buy |
|
|||||
|
2022
Q3 | $46.2M | Buy |
|
|||||
|
2022
Q2 | $44.4M | Sell |
|
|||||
|
2022
Q1 | $42M | Buy |
|
|||||
|
2021
Q4 | $3.06M | Sell |
|
|||||
|
2021
Q3 | $2.77M | Buy |
|
|||||
|
2021
Q2 | $2.58M | Buy |
|
|||||
|
2021
Q1 | $1.4M | Sell |
|
|||||
|
2020
Q4 | $15.5M | Buy |
|
|||||
|
2020
Q3 | $994K | Buy |
|
|||||
|
2020
Q2 | $901K | Buy |
|
|||||
|
2020
Q1 | $550K | Hold |
|
|||||
|
2019
Q4 | $550K | Sell |
|
|||||
|
2019
Q3 | $441 | Buy |
|
|||||
|
2019
Q2 | $424 | Buy |
|
|||||
|
2019
Q1 | $350 | Sell |
|
|||||
|
2018
Q4 | $361 | Buy |
|
|||||
|
2018
Q3 | $334K | Buy |
|
|||||
|
2018
Q2 | $288K | Sell |
|
|||||
|
2018
Q1 | $266K | Hold |
|
|||||
|
2017
Q4 | $266K | Buy |
|
|||||
|
2017
Q3 | $265K | Buy |
|
|||||
|
2017
Q2 | $180K | Hold |
|
|||||
|
2017
Q1 | $180K | Buy |
|
|||||
|
2016
Q4 | $72K | Sell |
|
|||||
|
2016
Q3 | $87K | Buy |
|
|||||
|
2016
Q2 | $60K | Buy |
|
|||||
|
2016
Q1 | $46K | Sell |
|
|||||
|
2015
Q4 | $94K | Hold |
|
|||||
|
2015
Q3 | $77K | Buy |
|
|||||
|
2015
Q2 | $85K | Sell |
|
|||||
|
2015
Q1 | $3.09M | Hold |
|
|||||
|
2014
Q4 | $3.11M | Buy |
|
|||||
|
2014
Q3 | $2.93M | Sell |
|
|||||
|
2014
Q2 | $2.49M | Sell |
|
|||||
|
2014
Q1 | $1.86M | Hold |
|
|||||
|
2013
Q4 | $1.96M | Buy |
|
|||||
|
2013
Q3 | $67K | Buy |
|
|||||
|
2013
Q2 | $53K | Buy |
|